Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Phase I Study

By Derks Michael   Anzures-Cabrera Judith   Turnbull Lynn   Phelan Mary  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Aliskiren in Healthy Chinese Subjects: A Randomized, Single-Blind, Parallel-Group, Placebo-Controlled Study

By Hu Pei  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 221-228

Adis International

Access to resources Recommend Favorite

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega‐3‐Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single‐Blind, Randomized, Placebo‐Controlled Trial

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 177-187

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Two 6-Day Frovatriptan Dosing Regimens Used for the Short-Term Prevention of Menstrual Migraine: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Single-Centre Study in Healthy Female Volunteers

By Wade Andrew  

Clinical Drug Investigation, Vol. 29, Iss. 5, 2009-01 ,pp. : 325-337

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 435-446

Adis International

Access to resources Recommend Favorite